Testing and Diagnosis

These webinars address topics in prostate cancer testing and diagnosis including: biomarkers for prostate cancer, PSA testing and understanding pathology reports.


2016 Webinars

Amplifying blood biomarkers with ultrasound to help predict the aggressiveness of prostate cancer

May 31, 2016

Join Dr. Roger Zemp to learn about how:
• Blood biomarkers are used in the detection of prostate cancer but may also offer promise in determining how aggressive a prostate cancer is
• Current biomarker testing cannot yet predict aggressiveness, in part due to the low levels of informative prostate biomarkers in the blood



2015 Webinars


Understanding Your Pathology Report with Dr. Dominque Trudel

July 14, 2015

In this Expert Angle webinar, Dr. Dominique Trudel presents "Understanding Your Pathology Report". During this webinar, you'll learn what is the significance of the pathology report, how is the prostate transformed to make it readable to the pathologist, and how does a pathologist analyze the prostate biopsy and the surgery specimen?


2014 Webinars


Role of MRI in Prostate Cancer Detection and Surveillance with Dr. Peter Black

April 29, 2014

During this webinar, Dr. Black discusses the evolving role of Magnetic Resonance Imaging (MRI) in prostate cancer, including its use in the early detection of prostate cancer, active surveillance for men with low risk prostate cancer, improving the accuracy of biopsies, and prostate cancer staging.


Predicting the Future with Dr. John Lewis

July 22, 2014

During this webinar, Dr. John Lewis will be discussing the use of biomarkers in prostate cancer diagnosis, including how biomarkers such as PSA are used today for prostate cancer management and how new biomarkers will allow patients and their physicians to make better treatment decisions.



Don't Throw the Baby Out with the Bathwater: The Benefits of PSA Testing with Dr. Andrew Loblaw

November 6, 2014

In response to the recommendations against PSA testing by the Canadian Task Force on Preventative Health Care, this Expert Angle webinar highlights the benefits of PSA testing with Dr. Andrew Loblaw.  In particular, Dr. Loblaw discusses the importance of active surveillance and its adoption in Canada, the need to measure baseline PSA to determine prostate cancer risk, and the use of modeling data to augment cohort data.

2013 Webinars


Prostate Cancer and PSA Testing with Dr. Tom Pickles

October 10, 2013

Dr. Tom Pickles presents “Prostate Cancer and PSA Testing”. This webinar covers what is PSA, diagnosis, screening, pre-treatment, and post-treatment.



En Français

Comprendre votre rapport de pathologie avec Dre Dominique Trudel

11 août 2015

Au cours de cette présentation, vous apprendrez comment la prostate est transformée pour être analysée par le pathologist, comment le pathologiste analyse la biopsie et le spécimen de chirurgie, et quelle est la signification du rapport de pathologie.



Facteurs de risque et diagnostic précoce du cancer de prostate avec Dre Alexandre Zlotta

1 septembre 2015

Regardez ce webinaire préenregistré de l’Angle de l’expert avec Dr Alexandre Zlotta. Facteurs de risque et diagnostic précoce du cancer de la prostate: ou en sommes-nous? Thèmes abordés...nouveaux facteurs de risque y compris les genes BRCA2, differences majeures entre prévalence, incidence et mortalité dues au cancer de la prostate, les nouveaux tests diagnostiques moléculaires, et la place grandissante de la resonance magnetique nucléaire.

Subscribe to our free monthly e-newsletter!

* indicates required


PCC Spotlight
RFP: Content Development and Delivery of an Accredited Electronic Continuing Medical Education Course for Prostate Cancer Specialists

Prostate Cancer Canada invites applications from service providers interested in the development, promotion and delivery of an accredited electronic Continuing Medical Education course targeting prostate cancer specialists, including urologists.

Prostate Cancer Canada announces new President and CEO

Toronto, December 21, 2017 – After five successful years under the leadership and guidance of outgoing President and CEO, Rocco Rossi, Prostate Cancer Canada (PCC) is excited to announce the appointment of a most worthy successor in Peter Coleridge, past national CEO of the Canadian Mental Health Association and current national President and CEO of Big Brothers Big Sisters of Canada.

Université de Sherbrooke Researchers’ Findings Published in Cancer Research

Sherbrooke, November 16, 2017 – Prostate cancer, the most common cancer in men, affects one out of seven Canadian men.

Click here for news archive